CD8A and neoplasm: In YTHDF1-deficient mice, the antigen-specific CD8+ T cell antitumor response increased compared with wild-type mice, relying on enhanced cross-presentation of tumor antigens and cross-priming of CD8+ T cells by classical dendritic cells (cDCs) (44).